Reversible Myopathy and Ophthalmoparesis After Low-Dose Finasteride Administration for Androgenic Alopecia
- 1 May 2014
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Dermatologic Surgery
- Vol. 40 (5), 595-597
- https://doi.org/10.1111/dsu.12458
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopeciaThe Journal of Dermatology, 2011
- Finasteride-Induced Myalgia and HyperCKemiaJournal of Clinical Neuromuscular Disease, 2008
- A review of the clinical efficacy and safety of 5α-reductase inhibitors for the enlarged prostateClinical Therapeutics, 2007
- Reversible severe myopathy during treatment with finasterideMuscle & Nerve, 1997